Hypoperfusion Intensity Ratio and Hemorrhagic Transformation in Patients with Successful Recanalization after Thrombectomy

References

1. 1.↵
   1. Ni H,
   2. Lu GD,
   3. Hang Y, et al

   . Association between infarct location and hemorrhagic transformation of acute ischemic stroke following successful recanalization after mechanical thrombectomy. AJNR Am J Neuroradiol 2023;44:54–59 doi:10.3174/ajnr.A7742 pmid:36521961

   Abstract/FREE Full Text
2. 2.↵
   1. Honig A,
   2. Percy J,
   3. Sepehry AA, et al

   . Hemorrhagic transformation in acute ischemic stroke: a quantitative systematic review. J Clin Med 2022;11:1162doi:10.3390/jcm11051162

   CrossRefPubMed
3. 3.↵
   1. Hong JM,
   2. Kim DS,
   3. Kim M

   . Hemorrhagic transformation after ischemic stroke: mechanisms and management. Front Neurol 2021;12:703258 doi:10.3389/fneur.2021.703258 pmid:34917010

   CrossRefPubMed
4. 4.↵
   1. Guenego A,
   2. Marcellus DG,
   3. Martin BW, et al

   . Hypoperfusion intensity ratio is correlated with patient eligibility for thrombectomy. Stroke 2019;50:917–22 doi:10.1161/STROKEAHA.118.024134 pmid:30841821

   CrossRefPubMed
5. 5.↵
   1. Faizy TD,
   2. Kabiri R,
   3. Christensen S, et al

   . Perfusion imaging-based tissue-level collaterals predict ischemic lesion net water uptake in patients with acute ischemic stroke and large vessel occlusion. J Cereb Blood Flow Metab 2021;41:2067–75 doi:10.1177/0271678X21992200 pmid:33557694

   CrossRefPubMed
6. 6.↵
   1. Olivot JM,
   2. Mlynash M,
   3. Inoue M, et al

   ; DEFUSE 2 Investigators. Hypoperfusion intensity ratio predicts infarct progression and functional outcome in the DEFUSE 2 Cohort. Stroke 2014;45:1018–23 doi:10.1161/STROKEAHA.113.003857 pmid:24595591

   Abstract/FREE Full Text
7. 7.↵
   1. Winkelmeier L,
   2. Heit JJ,
   3. Adusumilli G, et al

   . Hypoperfusion intensity ratio is correlated with the risk of parenchymal hematoma after endovascular stroke treatment. Stroke 2023;54:135–43 doi:10.1161/STROKEAHA.122.040540 pmid:36416127

   CrossRefPubMed
8. 8.↵
   1. Koneru M,
   2. Hoseinyazdi M,
   3. Wang R, et al

   . Pretreatment parameters associated with hemorrhagic transformation among successfully recanalized medium vessel occlusions. J Neurol 2024;271:1901–09 doi:10.1007/s00415-023-12149-4 pmid:38099953

   CrossRefPubMed
9. 9.↵
   1. Lee JS,
   2. Bang OY

   . Collateral status and outcomes after thrombectomy. Transl Stroke Res 2023;14:22–37 doi:10.1007/s12975-022-01046-z pmid:35687300

   CrossRefPubMed
10. 10.↵
    1. Ghozy S,
    2. Kacimi SEO,
    3. Azzam AY, et al

    . Successful mechanical thrombectomy in acute ischemic stroke: revascularization grade and functional independence. J Neurointerv Surg 2022;14:779–82 doi:10.1136/neurintsurg-2021-018436 pmid:35022301

    Abstract/FREE Full Text
11. 11.↵
    1. Chen L,
    2. Xu Z,
    3. Zhang C, et al

    . Post-ASPECTS based on hyperdensity in NCCT immediately after thrombectomy is an ultra-early predictor of hemorrhagic transformation and prognosis. Front Neurol 2022;13:887277 doi:10.3389/fneur.2022.887277 pmid:36034273

    CrossRefPubMed
12. 12.↵
    1. Faizy TD,
    2. Kabiri R,
    3. Christensen S, et al

    . Favorable venous outflow profiles correlate with favorable tissue-level collaterals and clinical outcome. Stroke 2021;52:1761–67 doi:10.1161/STROKEAHA.120.032242 pmid:33682452

    CrossRefPubMed
13. 13.↵
    1. van Horn N,
    2. Broocks G,
    3. Kabiri R, et al

    . Cerebral hypoperfusion intensity ratio is linked to progressive early edema formation. J Clin Med 2022;11:2373 doi:10.3390/jcm11092373

    CrossRefPubMed
14. 14.↵
    1. Sarraj A,
    2. Albers GW,
    3. Mitchell PJ, et al

    . Thrombectomy outcomes with general vs nongeneral anesthesia: a pooled patient-level analysis from the EXTEND-IA Trials and SELECT Study. Neurology 2023;100:e336–e347 doi:10.1212/WNL.0000000000201384 pmid:36289001

    Abstract/FREE Full Text
15. 15.↵
    1. Hacke W,
    2. Kaste M,
    3. Fieschi C, et al

    . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245–51 doi:10.1016/s0140-6736(98)08020-9 pmid:9788453

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Tsui B,
    2. Chen IE,
    3. Nour M, et al

    . Perfusion collateral index versus hypoperfusion intensity ratio in assessment of collaterals in patients with acute ischemic stroke. AJNR Am J Neuroradiol 2023;44:1249–55 doi:10.3174/ajnr.A8002 pmid:37827719

    Abstract/FREE Full Text
17. 17.↵
    1. Adusumilli G,
    2. Kobeissi H,
    3. Ghozy S, et al

    . Hypoperfusion intensity ratio as a predictor of outcomes after thrombectomy triage: a call for data homogeneity. Interv Neuroradiol 2023 Jul 18. [Epub ahead of print] doi:10.1177/15910199231188763 pmid:37461822

    CrossRefPubMed
18. 18.↵
    1. Lyndon D,
    2. van den Broek M,
    3. Niu B, et al

    . Hypoperfusion intensity ratio correlates with CTA collateral status in large-vessel occlusion acute ischemic stroke. AJNR Am J Neuroradiol 2021;42:1380–86 doi:10.3174/ajnr.A7181 pmid:34140276

    Abstract/FREE Full Text
19. 19.↵
    1. Uniken Venema SM,
    2. Dankbaar JW,
    3. van der Lugt A, et al

    . Cerebral collateral circulation in the era of reperfusion therapies for acute ischemic stroke. Stroke 2022;53:3222–34 doi:10.1161/STROKEAHA.121.037869 pmid:35938420

    CrossRefPubMed
20. 20.↵
    1. Lin L,
    2. Yang J,
    3. Chen C, et al

    ; INSPIRE Study Group. Association of collateral status and ischemic core growth in patients with acute ischemic stroke. Neurology 2021;96:e161–70 doi:10.1212/WNL.0000000000011258 pmid:33262233

    Abstract/FREE Full Text
21. 21.↵
    1. Seifert K,
    2. Heit JJ

    . Collateral blood flow and ischemic core growth. Transl Stroke Res 2023;14:13–21 doi:10.1007/s12975-022-01051-2 pmid:35699917

    CrossRefPubMed
22. 22.↵
    1. Patel SD,
    2. Liebeskind D

    . Collaterals and elusive ischemic penumbra. Transl Stroke Res 2023;14:3–12 doi:10.1007/s12975-022-01116-2 pmid:36580264

    CrossRefPubMed
23. 23.↵
    1. Hashimoto T,
    2. Kunieda T,
    3. Honda T, et al

    . Reduced leukoaraiosis, noncardiac embolic stroke etiology, and shorter thrombus length indicate good leptomeningeal collateral flow in embolic large-vessel occlusion. AJNR Am J Neuroradiol 2022;43:63–69 doi:10.3174/ajnr.A7360 pmid:34794948

    Abstract/FREE Full Text
24. 24.↵
    1. Semerano A,
    2. Laredo C,
    3. Zhao Y, et al

    . Leukocytes, collateral circulation, and reperfusion in ischemic stroke patients treated with mechanical thrombectomy. Stroke 2019;50:3456–64 doi:10.1161/STROKEAHA.119.026743 pmid:31619153

    CrossRefPubMed
25. 25.↵
    1. Little JR,
    2. Kerr FW,
    3. Sundt TM. Jr,.

    . Microcirculatory obstruction in focal cerebral ischemia: an electron microscopic investigation in monkeys. Stroke 1976;7:25–30 doi:10.1161/01.STR.7.1.25 pmid:31815406

    Abstract/FREE Full Text
26. 26.↵
    1. Bonnin P,
    2. Kubis N,
    3. Charriaut-Marlangue C

    . Collateral supply in preclinical cerebral stroke models. Transl Stroke Res 2022;13:512–27 doi:10.1007/s12975-021-00969-3 pmid:34797519

    CrossRefPubMed
27. 27.↵
    1. Fan JL,
    2. Brassard P,
    3. Rickards CA, et al

    . Integrative cerebral blood flow regulation in ischemic stroke. J Cereb Blood Flow Metab 2022;42:387–403 doi:10.1177/0271678X211032029 pmid:34259070

    CrossRefPubMed
28. 28.↵
    1. Mangiardi M,
    2. Bonura A,
    3. Iaccarino G, et al

    . The pathophysiology of collateral circulation in acute ischemic stroke. Diagnostics (Basel) 2023;13:2425 doi:10.3390/diagnostics13142425

    CrossRefPubMed
29. 29.↵
    1. Lim S,
    2. Kim TJ,
    3. Kim YJ, et al

    . Senolytic therapy for cerebral ischemia-reperfusion injury. Int J Mol Sci 2021;22:11967 doi:10.3390/ijms222111967

    CrossRefPubMed
30. 30.↵
    1. Przykaza Ł

    . Understanding the connection between common stroke comorbidities, their associated inflammation, and the course of the cerebral ischemia/reperfusion cascade. Front Immunol 2021;12:782569 doi:10.3389/fimmu.2021.782569 pmid:34868060

    CrossRefPubMed
31. 31.↵
    1. Jurcau A,
    2. Simion A

    . Neuroinflammation in cerebral ischemia and ischemia/reperfusion injuries: from pathophysiology to therapeutic strategies. Int J Mol Sci 2021;23:140 doi:10.3390/ijms23010014

    CrossRefPubMed
32. 32.↵
    1. Ciacciarelli A,
    2. Tessitore A,
    3. Fiume G, et al

    . Factors associated with hemorrhagic transformation after endovascular treatment despite early recanalization. J Neurol Sci 2023;453:120778 doi:10.1016/j.jns.2023.120778 pmid:37669577

    CrossRefPubMed
33. 33.↵
    1. Cappellari M,
    2. Pracucci G,
    3. Saia V, et al

    . Predictors for hemorrhagic transformation and cerebral edema in stroke patients with first-pass complete recanalization. Int J Stroke 2023;18:1238–46 doi:10.1177/17474930231185690 pmid:37337362

    CrossRefPubMed
34. 34.↵
    1. Fanou EM,
    2. Knight J,
    3. Aviv RI, et al

    . Effect of collaterals on clinical presentation, baseline imaging, complications, and outcome in acute stroke. AJNR Am J Neuroradiol 2015;36:2285–91 doi:10.3174/ajnr.A4453 pmid:26471754

    Abstract/FREE Full Text
35. 35.↵
    1. Hornig CR,
    2. Bauer T,
    3. Simon C, et al

    . Hemorrhagic transformation in cardioembolic cerebral infarction. Stroke 1993;24:465–68 doi:10.1161/01.str.24.3.465 pmid:8446984

    Abstract/FREE Full Text
36. 36.↵
    1. Escudero-Martínez I,
    2. Morales-Caba L,
    3. Segura T

    . Atrial fibrillation and stroke: A review and new insights. Trends Cardiovasc Med 2023;33:23–29 doi:10.1016/j.tcm.2021.12.001 pmid:34890796

    CrossRefPubMed
37. 37.↵
    1. Kamel H,
    2. Healey JS

    . Cardioembolic stroke. Circ Res 2017;120:514–26 doi:10.1161/CIRCRESAHA.116.308407 pmid:28154101

    Abstract/FREE Full Text
38. 38.↵
    1. Wysocka A,
    2. Szczygielski J,
    3. Kopańska M, et al

    . Matrix metalloproteinases in cardioembolic stroke: from background to complications. Int J Mol Sci 2023;24:24 doi:10.3390/ijms24043628 pmid:36835040

    CrossRefPubMed